Skip to content

FP7H2020HORIZON

Istituto di Ricerche Farmacologiche Mario Negri

Country
ITItaly
Defence projects
0
Projects, all programmes
85
As coordinator
16
EU contribution (CORDIS)
EUR 39,287,282
Active
2008 to 2025

Projects

85 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
TRANCYSTTranslational research (training) in Polycystic Kidney DiseaseFP72012ParticipantEUR 243,038
TINN2Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonatesFP72011ParticipantEUR 252,000
OPENOvercome failure to Publish nEgative fiNdingsFP72011ParticipantEUR 36,594
COHEMICoordinating resources to assess and improve health status of migrants from Latin AmericaFP72011CoordinatorEUR 419,809
RESETDreaming of no more renal dialysis: how self-derived tissue and cells can replace renal functionFP72011CoordinatorEUR 2,493,000
EURO-MOTOREuropean multidisciplinary ALS network identification to cure motor neuron degenerationFP72011ParticipantEUR 372,720
TOXBANKToxBank – Supporting Integrated Data Analysis and Servicing of Alternative Testing Methods in ToxicologyFP72011CoordinatorEUR 250,316
SYSKIDSystems biology towards novel chronic kidney disease diagnosis and treatmentFP72010ParticipantEUR 457,160
FOCUSFixed Dose Combination drugs for Secondary Cardiovascular PreventionFP72010ParticipantEUR 500,000
HYGIENETHE HYGIENE HYPOTHESIS : REVISITING THE CONCEPT BY INTEGRATING EPIDEMIOLOGY AND MECHANISTIC STUDIESFP72010ParticipantEUR 1,001,679
PHARMA-COGPrediction of cognitive properties of new drug candidates for neurodegenerative diseases in the early clinical developmentFP72010ParticipantEUR 549,000
ORCHESTRAOrganising dissemination on Results of projects on Chemical Evaluation, Spreading Techniques for Risk AssessmentFP72009CoordinatorEUR 260,583
SUMMITSUrrogate markers for vascular Micro- and Macrovascular hard endpoints for Innovative diabetes ToolsFP72009ParticipantEUR 184,999
RISKCYCLERisk-based management of chemicals and products in a circular economy at a global scaleFP72009ParticipantEUR 58,850
PPACTEPricing Policies and Control of Tobacco in EuropeFP72009ParticipantEUR 516,868
ENBRECEuropean Network of Bipolar Research Expert CentresFP72009ParticipantEUR 85,550
EPOCEuropean Paediatric Oncology Off-Patent Medicines ConsortiumFP72009ParticipantEUR 194,541
PROTECTPharmacoepidemiolocal Research on Outcomes of Therapeutics by a European ConsorTiumFP72009ParticipantEUR 232,500
ECRIN-PPIEuropean clinical research infrastructures network for clinical trials and biotherapy - preparatory phase for the infrastructureFP72008ParticipantEUR 399,700
TINNEvaluation of antibiotics (ciprofloxacin and fluconazole) for the treatment of infections in preterm and term neonatesFP72008ParticipantEUR 185,509

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.